(Q42540522)

English

Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver

scientific article published on July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 November 2017

Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver (English)

1 reference

Europe PubMed Central

2 November 2017

0 references

stereoselectivity

1 reference

based on heuristic

inferred from title

author name string

Rochat B

1

1 reference

Europe PubMed Central

2 November 2017

Kosel M

2

1 reference

Europe PubMed Central

2 November 2017

Boss G

3

1 reference

Europe PubMed Central

2 November 2017

Testa B

4

1 reference

Europe PubMed Central

2 November 2017

Gillet M

5

1 reference

Europe PubMed Central

2 November 2017

Baumann P

6

1 reference

Europe PubMed Central

2 November 2017

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

2 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

2 November 2017

56

1 reference

Europe PubMed Central

2 November 2017

1

1 reference

Europe PubMed Central

2 November 2017

15-23

1 reference

Europe PubMed Central

2 November 2017

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Xenobiotic oxidation catalyzed by aldehyde dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Metabolic formation of dimethylamine and methylamine from basic drugs containing N-methyl group: a newly established chromatographic assay and its application to the determination of deaminase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Hepatic microsomal oxygenation of aldehydes to carboxylic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Interactions of monoamine oxidase with substrates and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Flauoprotein structure and mechanism 2. Monoamine oxidases: old friends hold many surprises.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Metabolism of diltiazem. III. Oxidative deamination of diltiazem in rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography—mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Inhibition by SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Use of in vitro human metabolism studies in drug development. An industrial perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Tyramine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Adrenaline and amine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

On the stereospecificity of monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Xenobiotic metabolism in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900008-2

7 January 2021

Identifiers

10.1016/S0006-2952(98)00008-2

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42540522&oldid=1961239012"